Opinion on Pharmaceuticals in North America

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Mylan Pharmaceuticals: realistic outlook at last

Published By Datamonitor
11 Apr 2001
Expert View
Expert View

Needless needles new technologies for vaccine delivery

Published By Datamonitor
11 May 2001
CommentWire
CommentWire

Durect: DUROS to cut the pain

Published By Datamonitor
15 May 2001
CommentWire
CommentWire

US cholesterol: generics to benefit most from guidelines

Published By Datamonitor
16 May 2001
Expert View
Expert View

The changing face of generics

Published By Datamonitor
08 Jun 2001
CommentWire
CommentWire

GSK/Novartis: antibiotic patent row

Published By Datamonitor
12 Jun 2001
CommentWire
CommentWire

GSK: increased safety to drive hepatitis vaccine growth

Published By Datamonitor
19 Jun 2001
CommentWire
CommentWire

Barr/Duramed: emerging from the generics market

Published By Datamonitor
03 Jul 2001
CommentWire
CommentWire

Faulding's folding: a generic expansion opportunity

Published By Datamonitor
18 Jul 2001
CommentWire
CommentWire

Barr: a major OC generic competitor

Published By Datamonitor
17 Aug 2001

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.